RIS Rx Introduces New Brand Platform: GTN Revenue Protection

RIS Rx Introduces New Brand Platform: GTN Revenue Protection

March 18, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
Our StoryPress Releases
Get GTN Insights by Email
From Leakage to Leverage: How RIS Rx Is Redefining Patient Affordability at Scale
From Leakage to Leverage: How RIS Rx Is Redefining Patient Affordability at Scale

February 17, 2026

Gerard Rivera
Gerard Rivera Co-founder & CEO
GTN Insights
Welcoming Leslie Donato to our Board of Directors
Welcoming Leslie Donato to our Board of Directors

December 22, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our PeoplePress Releases
Welcoming Stuart McGuigan to our Board of Directors
Welcoming Stuart McGuigan to our Board of Directors

December 17, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our PeoplePress Releases
Grateful for the People Behind the Progress
Grateful for the People Behind the Progress

November 25, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our People
Closing the Affordability Gap in Real Time
Closing the Affordability Gap in Real Time

November 25, 2025

Stephen Hom
Stephen Hom Co-founder & COO
Our Story
GTN Leakage Is Overwhelming Pharma Leaders—and It Shouldn’t Be
GTN Leakage Is Overwhelming Pharma Leaders—and It Shouldn’t Be

November 18, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
PBM / Payer-based Leakage
Affordability Programs Aren’t Optional. They’re Life-Saving.
Affordability Programs Aren’t Optional. They’re Life-Saving.

October 30, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
PBM / Payer-based Leakage
From Copay Blind Spots to $1B Saved: Why We Built RIS Rx
From Copay Blind Spots to $1B Saved: Why We Built RIS Rx

October 24, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our Story
Welcoming John Driscoll as Chairman of our Board of Directors
Welcoming John Driscoll as Chairman of our Board of Directors

October 15, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our PeoplePress Releases

Learn why the world‘s top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.